NCT06335524 Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
| NCT ID | NCT06335524 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Child Development |
| Study Type | INTERVENTIONAL |
| Enrollment | 188 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 188 participants in total. It began in 2024-11-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will test the hypothesis that in preterm infants a caregiver-implemented early developmental intervention (EDI) using finger puppets to develop joint attention and encourage interactive communication with routine EDI care including Bookworm training compared with routine EDI care including Bookworm training alone will increase the Ages and Stages Questionnaire® score at 12 months corrected age.
Eligibility Criteria
Inclusion Criteria: * inborn at UAB, delivered at less than 34 weeks' gestation, 32-39 weeks' PMA, off sedatives, and off invasive respiratory support. Exclusion Criteria: * a major malformation, a known syndrome, enrolled in a competing trial targeting neurodevelopmental outcomes as a primary outcome.
Contact & Investigator
Colm P Travers
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT06335524 clinical trial?
This trial is open to participants of all sexes, aged 1 Week or older, up to 17 Weeks, studying Child Development. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06335524 currently recruiting?
Yes, NCT06335524 is actively recruiting participants. Contact the research team at thgarcia@uabmc.edu for enrollment information.
Where is the NCT06335524 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT06335524 clinical trial?
NCT06335524 is sponsored by University of Alabama at Birmingham. The principal investigator is Colm P Travers at University of Alabama at Birmingham. The trial plans to enroll 188 participants.